Colorectal cancer in inflammatory bowel disease: a shift in risk?

References

• Shanahan F. Relation between colitis and colon cancer. Lancet 2001;357:246-7
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011;140:1807-16
   PubMed Web of Science ®Google Scholar
• Ahmadi A. Colorectal cancer surveillance in inflammatory bowel disease: The search continues. World J Gastroentero 2009;15:61
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6
   PubMed Web of Science ®Google Scholar
• Ullman TA, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon. Inflamm Bowel Dis 2009;15:630-8
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;323:1228-33
   PubMed Web of Science ®Google Scholar
• Rubin DT. The Changing face of colorectal cancer in inflammatory bowel disease: progress at last!. Gastroenterology 2006;130:1350-2
   PubMed Web of Science ®Google Scholar
• Jess T, Simonsen J, Jørgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375-81
   PubMed Web of Science ®Google Scholar
• Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-9
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166-75. e8
   PubMed Web of Science ®Google Scholar
• De Dombal FT. Ulcerative colitis. epidemiology and aetiology, course and prognosis. Br Med J 1971;1:649
   PubMed Web of Science ®Google Scholar
• Eaden JA. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35
   PubMed Web of Science ®Google Scholar
• Sugita A, Sachar DB, Bodian C, et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167-9
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9
   PubMed Web of Science ®Google Scholar
• Gupta RB, Harpaz N, Itzkowitz SH, et al. Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: a Cohort Study. Gastroenterology 2007;133:1099-105
   PubMed Web of Science ®Google Scholar
• Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Gastroenterology 2010;138:746-74
   PubMed Web of Science ®Google Scholar
• McKenna BJ, Appelman HD. Dysplasia can be a pain in the gut. Pathology 2002;34:518-28
   PubMed Web of Science ®Google Scholar
• Lepistö A, Kärkkäinen P, Järvinen HJ. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. Inflamm Bowel Dis 2008;14:775-9
   PubMed Web of Science ®Google Scholar
• Eaden JA, Mayberry JF; British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51(Suppl 5):10-12
   Google Scholar
• Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn’s Colitis 2013;7:982-1018
   Google Scholar
• Askling J, Dickman PW, Karlén P, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 2001;357:262-6
   PubMed Web of Science ®Google Scholar
• Lutgens MWMD, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009;101:1671-5
   PubMed Web of Science ®Google Scholar
• Maykel JA, Hagerman G, Mellgren AF, et al. Crohn’s Colitis: the Incidence of Dysplasia and Adenocarcinoma in Surgical Patients. Dis Colon Rectum 2006;49:950-7
   PubMed Web of Science ®Google Scholar
• Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharm Therap 2003;18(Suppl 2):1-5
   PubMed Web of Science ®Google Scholar
• Gyde SN, Prior P, Macartney JC, et al. Malignancy in Crohn’s disease. Gut 1980;21:1024-9
   PubMed Web of Science ®Google Scholar
• Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-2
   PubMed Web of Science ®Google Scholar
• Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharm Therap 2006;23:1097-104
   PubMed Web of Science ®Google Scholar
• Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824
   PubMed Web of Science ®Google Scholar
• Arnold Bargen J. Chronic ulcerative colitis associated with malignant disease. Dis Colon Rectum 1994;37:727-30
   PubMed Web of Science ®Google Scholar
• Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243-51
   PubMed Web of Science ®Google Scholar
• Barclay T, Schapira DV. Malignant tumors of the small intestine. Cancer 1983;51:878-81
   PubMed Web of Science ®Google Scholar
• Lutgens MWMD, van Oijen MGH, van der Heijden GJMG, et al. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease. Inflamm Bowel Dis 2013;19:789-99
   PubMed Web of Science ®Google Scholar
• Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004;2:1088-95
   PubMed Web of Science ®Google Scholar
• Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999;117:1295-300
   PubMed Web of Science ®Google Scholar
• Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999;117:1488-91
   PubMed Web of Science ®Google Scholar
• Arber N, Levin B. Chemoprevention of Colorectal Neoplasia: the Potential for Personalized Medicine. Gastroenterology 2008;134:1224-37
   PubMed Web of Science ®Google Scholar
• Velayos FS, Terdiman JP, Walsh JM. Effect of 5-Aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and meta-analysis of observational studies. Am J Gastroenterol 2005;100:1345-53
   PubMed Web of Science ®Google Scholar
• Söderlund S, Brandt L, Lapidus A, et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009;136(5):1561-7
   PubMed Web of Science ®Google Scholar
• Velayos FS, Loftus EV, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 2006;130:1941-9
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Gulamhusein A, Bernstein CN. 5-Aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations. Am J Gastroenterol 2012;107:1298-304
   PubMed Web of Science ®Google Scholar
• Pardi DS, Loftus EV Jr, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889-93
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89-95
   PubMed Web of Science ®Google Scholar
• Jess T, Riis L, Vind I, et al. Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: a Population-Based Study from Copenhagen, Denmark. Inflamm Bowel Dis 2007;13:481-9
   PubMed Web of Science ®Google Scholar
• Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003;58:S3-S43
   PubMed Web of Science ®Google Scholar
• Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68
   PubMed Web of Science ®Google Scholar
• Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Frick K, Dassopolous T. Medical decision analysis for the management of unifocal, flat, low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 2009;69:1299-310
   PubMed Web of Science ®Google Scholar
• Ullman TA, Croog V, Harpaz N, et al. Progression of Flat Low-Grade Dysplasia to Advanced Neoplasia in Patients With Ulcerative Colitis. Gastroenterology 2003;125:1311-19
   PubMed Web of Science ®Google Scholar
• Gorfine SR, Bauer JJ, Harris MT, Kreel I. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted? Dis Colon Rectum 2000;43:1575-81
   PubMed Web of Science ®Google Scholar
• Korelitz BI, Lauwers GY, Sommers SC. Rectal mucosal dysplasia in Crohn’s disease. Gut 1990;31:1382-6
   PubMed Web of Science ®Google Scholar
• Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004;2:534-41
   PubMed Web of Science ®Google Scholar
• Suzuki K, Muto T, Shinozaki M, et al. Differential diagnosis of dysplasia-associated lesion or mass and coincidental adenoma in ulcerative colitis. Dis Colon Rectum 1998;41:322-7
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Present DH; Crohn’s and Colitis Foundation of America Colon Cancer in IBD Study Group. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005;314-21
   PubMed Web of Science ®Google Scholar
• Dixon MF, Brown LJ, Gilmour HM, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-97
   PubMed Web of Science ®Google Scholar
• Allen DC, Hamilton PW, Watt PC, Biggart JD. Morphometrical analysis in ulcerative colitis with dysplasia and carcinoma. Histopathology 1987;11:913-26
   PubMed Web of Science ®Google Scholar
• van Schaik FDM, Kate ten FJW, Offerhaus JGA, et al. Misclassification of dysplasia in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1108-16
   PubMed Web of Science ®Google Scholar
• Murthy SK, Kiesslich R. Evolving endoscopic strategies for detection and treatment of neoplastic lesions in inflammatory bowel disease. Gastrointest Endosc 2013;77:351-9
   PubMed Web of Science ®Google Scholar
• Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006(2):CD000279
   PubMed Web of Science ®Google Scholar
• Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59(5):666-89
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Sachar DB. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-23
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn’s Disease in Adults. Am J Gastroenterol 2009;104:465-83
   PubMed Web of Science ®Google Scholar
• Leighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006;63:558-65
   PubMed Web of Science ®Google Scholar
• Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Gastroenterology 2010;138:738-45
   PubMed Web of Science ®Google Scholar
• Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005;62:1-8
   PubMed Web of Science ®Google Scholar
• Reddy SI, Friedman S, Telford JJ, et al. Are Patients with Inflammatory Bowel Disease Receiving Optimal Care? Am J Gastroenterol 2005;100:1357-61
   PubMed Web of Science ®Google Scholar
• Baars JE, Siegel CA, Spijker AV, et al. Digestive and liver Disease. Dig Liver Dis 2010;42:777-84
   PubMedGoogle Scholar
• Hudson B, Green JT, Lockett M. Updated BSG guidelines for cancer surveillance in IBD - improving consensus and changing practice? Gut 2011;60:A203-4
   Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82
   PubMed Web of Science ®Google Scholar
• Subramanian V, Mannath J, Ragunath K, Hawkey CJ. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2010;33:304-12
   PubMed Web of Science ®Google Scholar
• Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14
   PubMed Web of Science ®Google Scholar
• de Melo SW Jr, Wallace MB. Endoscopic colorectal imaging and therapy. Curr Opin Gastroenterol 2011;27:54-60
   PubMed Web of Science ®Google Scholar
• Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012;107:885-90
   PubMed Web of Science ®Google Scholar
• Pellisé M, López-Cerón M, de Miguel CR, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011;74:840-8
   PubMed Web of Science ®Google Scholar
• Bisschops R, Bessissow T, Baert FJ, et al. Chromo-endoscopy versus narrow band imaging in ulcerative colitis: a prospective randomized controlled trial. Gastrointest Endosc 2012;75:A148
   Web of Science ®Google Scholar
• Mannath J, Subramanian V, Hawkey C, Ragunath K. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis. Endoscopy 2010;42:351-9
   PubMed Web of Science ®Google Scholar
• Wu L, Li Y, Li Z, et al. Diagnostic accuracy of narrow-band imaging for the differentiation of neoplastic from non-neoplastic colorectal polyps: a meta-analysis. Colorectal Dis 2012;15:3-11
   Web of Science ®Google Scholar
• Bessissow T, Bisschops R. Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis. Expert Rev Gastroenterol Hepatol 2013;7:57-67
   PubMed Web of Science ®Google Scholar
• S Kwon R, Wong Kee Song L-M, G Adler D, et al. Endocytoscopy. Gastrointest Endosc 2009;70:610-13
   PubMed Web of Science ®Google Scholar
• Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006;130:1039-46
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8
   PubMed Web of Science ®Google Scholar
• Ullman TA. Inflammatory bowel disease-associated cancers: does gender change incidence? Gastroenterology 2010;138:1658-60
   PubMed Web of Science ®Google Scholar